Study of the Effects of Fabrazyme Treatment on Lactation and Infants

NCT00230607 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Per FDA decision, the 2003 Post Marketing commitment has been fulfilled.

Conditions

Fabry Disease
Alpha Galactosidase A Deficiency

Interventions

DRUG: agalsidase beta

Sponsor

Genzyme, a Sanofi Company